- MetLife’s adjusted earnings per share (EPS) for Q4 was $2.09, slightly below the estimated $2.10.
- Adjusted revenue reached $19.74 billion, exceeding the expectation of $19.51 billion.
- Premiums, fees, and other revenues amounted to $14.48 billion.
- Net investment income was $5.41 billion, outperforming the projection of $5.22 billion.
- Book value per share fell short at $34.28 compared to the estimate of $40.32.
- The return on equity was a robust 19.6%.
- MetLife reported an expense ratio of 17.8%.
- There was an 8% decline in retirement and income solutions adjusted earnings.
- Asia saw a 50% increase in adjusted earnings.
- EMEA reported a 26% growth in adjusted earnings.
- MetLife Holdings experienced a decrease of 2% in adjusted earnings.
- Analyst recommendations included 13 buy ratings, 4 hold ratings, and 1 sell rating.
Metlife Inc on Smartkarma
Analyst coverage on MetLife Inc. by Baptista Research on Smartkarma showcases a positive outlook on the company’s financial landscape. In their report “MetLife Inc: Dealing With The Japan Market Dynamics & Executing Strategic Diversification To Up Their Game! – Major Drivers,” Baptista Research delves into the complexities shaped by investments, market conditions, and strategic initiatives. MetLife reported adjusted earnings of $1.4 billion or $1.95 per share in the third quarter of 2024, highlighting challenges amid variable investment income pressures and market dynamics.
Furthermore, in another report titled “MetLife Inc.: How Are They Adapting To The Interest Rate Environment? – Major Drivers,” Baptista Research emphasizes MetLife’s strong financial performance in the second quarter of 2024. The company’s adjusted earnings of $1.6 billion or $2.28 per share reflected robust underwriting results and solid variable investment income despite economic fluctuations. The reports shed light on MetLife’s resilience and adaptability in navigating the evolving financial landscape.
A look at Metlife Inc Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
MetLife Inc, a prominent provider of insurance, benefits, and financial services globally, has garnered respectable marks across various key areas according to Smartkarma Smart Scores. With solid scores in resilience and momentum, the company seems well-equipped to weather market uncertainties and capitalize on positive trends. While the scores for value, dividend, and growth are moderate, indicating a stable foundation without explosive growth potential, the overall outlook appears steady and reliable based on the current assessments.
MetLife Inc operates in a wide array of regions, offering a diverse range of products including life insurance, annuities, and various financial services both to individuals and groups. The company’s resilience and momentum scores suggest a capability to adapt to changing market conditions and maintain an upward trajectory. For investors seeking a balanced investment with a solid track record, MetLife Inc could be an attractive option given its consistent performance across key parameters.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
